These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 11401911)

  • 1. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses.
    Rivkina MB; Cullen JM; Robinson WS; Marion PL
    Cancer Res; 1994 Oct; 54(20):5430-7. PubMed ID: 7923176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
    El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
    J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
    Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
    Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
    Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
    Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
    Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
    Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
    Ghebranious N; Sell S
    Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
    Chen Ban K; Singh H; Krishnan R; Fong Seow H
    J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.